Testing effectiveness (Phase 2)Study completedNCT03011528
What this trial is testing
First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years (CombinaiR3)
Who this might be right for
Ewing Sarcoma Family of Tumors
Institut Curie 45